PMV Pharmaceuticals, Inc. (PMVP)
PMVP Stock Price Chart
Explore PMV Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze PMVP price movements and trends.
PMVP Company Profile
Discover essential business fundamentals and corporate details for PMV Pharmaceuticals, Inc. (PMVP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
25 Sept 2020
Employees
47.00
Website
https://www.pmvpharma.comCEO
David H. Mack
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.
PMVP Financial Timeline
Browse a chronological timeline of PMV Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 2 Mar 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.41.
Earnings released on 7 Aug 2025
EPS came in at -$0.41 falling short of the estimated -$0.39 by -5.13%.
Earnings released on 9 May 2025
EPS came in at -$0.34 surpassing the estimated -$0.37 by +8.11%.
Earnings released on 3 Mar 2025
EPS came in at -$0.45 falling short of the estimated -$0.38 by -18.42%.
Earnings released on 7 Nov 2024
EPS came in at -$0.37 falling short of the estimated -$0.35 by -5.71%.
Earnings released on 8 Aug 2024
EPS came in at -$0.02 surpassing the estimated -$0.34 by +94.12%.
Earnings released on 9 May 2024
EPS came in at -$0.30 surpassing the estimated -$0.35 by +14.29%.
Earnings released on 29 Feb 2024
EPS came in at -$0.31 surpassing the estimated -$0.39 by +20.51%.
Earnings released on 9 Nov 2023
EPS came in at -$0.34 surpassing the estimated -$0.45 by +24.44%.
Earnings released on 9 Aug 2023
EPS came in at -$0.38 surpassing the estimated -$0.47 by +19.15%.
Earnings released on 10 May 2023
EPS came in at -$0.42 surpassing the estimated -$0.48 by +12.50%.
Earnings released on 1 Mar 2023
EPS came in at -$0.43 surpassing the estimated -$0.44 by +2.27%.
Earnings released on 8 Nov 2022
EPS came in at -$0.40 surpassing the estimated -$0.42 by +4.76%.
Earnings released on 9 Aug 2022
EPS came in at -$0.38 surpassing the estimated -$0.41 by +7.32%.
Earnings released on 10 May 2022
EPS came in at -$0.41 surpassing the estimated -$0.42 by +2.38%.
Earnings released on 1 Mar 2022
EPS came in at -$0.41 falling short of the estimated -$0.35 by -17.14%.
Earnings released on 12 Nov 2021
EPS came in at -$0.33 falling short of the estimated -$0.31 by -6.45%.
Earnings released on 13 Aug 2021
EPS came in at -$0.29 matching the estimated -$0.29.
Earnings released on 14 May 2021
EPS came in at -$0.26 matching the estimated -$0.26.
Earnings released on 3 Mar 2021
EPS came in at $3.53 surpassing the estimated -$0.57 by +719.30%.
Earnings released on 13 Nov 2020
EPS came in at -$1.46 falling short of the estimated -$0.34 by -329.41%.
Earnings released on 25 Sept 2020
EPS came in at -$0.23 .
PMVP Stock Performance
Access detailed PMVP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.